Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Research advances in peptide‒drug conjugates
Liming Gong, Heming Zhao, Yanhong Liu, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 9, pp. 3659-3677
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Antibody–drug conjugates: Recent advances in payloads
Zhijia Wang, Hanxuan Li, Lantu Gou, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 10, pp. 4025-4059
Open Access | Times Cited: 76
Bispecific antibody drug conjugates: Making 1+1>2
Yilin Gu, Zhijia Wang, Yuxi Wang
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 5, pp. 1965-1986
Open Access | Times Cited: 24
Peptide-drug conjugates: A new paradigm for targeted cancer therapy
Mo Wang, Jiawei Liu, Mingjing Xia, et al.
European Journal of Medicinal Chemistry (2024) Vol. 265, pp. 116119-116119
Closed Access | Times Cited: 21
Advances in peptide-based drug delivery systems
Sijie Guo, Jing Wang, Qi Wang, et al.
Heliyon (2024) Vol. 10, Iss. 4, pp. e26009-e26009
Open Access | Times Cited: 12
Peptide-Drug Conjugates: Design, Chemistry, and Drug Delivery System as a Novel Cancer Theranostic
Syed Faheem Askari Rizvi, Lin‐Jie Zhang, Haixia Zhang, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 2, pp. 309-334
Open Access | Times Cited: 11
Cysteine‐Specific Multifaceted Bioconjugation of Peptides and Proteins Using 5‐Substituted 1,2,3‐Triazines
Quan Zuo, Yiping Li, Xuanliang Lai, et al.
Advanced Science (2024) Vol. 11, Iss. 21
Open Access | Times Cited: 8
Antibody-drug conjugates for targeted cancer therapy: recent advances in potential payloads
Meiyang Xi, Jingjing Zhu, Fengxia Zhang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116709-116709
Closed Access | Times Cited: 8
Engineering peptide drug therapeutics through chemical conjugation and implication in clinics
Syed Faheem Askari Rizvi, Haixia Zhang, Quan Fang
Medicinal Research Reviews (2024) Vol. 44, Iss. 6, pp. 2420-2471
Closed Access | Times Cited: 6
Key considerations based on pharmacokinetic/pharmacodynamic in the design of antibody-drug conjugates
Yangyang Gao, Yuwei Xia, Yixin Chen, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Design and Synthesis of Isatin Derivative Payloaded Peptide-Drug Conjugate as Tubulin Inhibitor against Colorectal Cancer
Guoyang Sun, Zhao‐Yang Wang, Yanping Li, et al.
European Journal of Medicinal Chemistry (2025) Vol. 285, pp. 117276-117276
Closed Access
Recent Advances in Targeted Cancer Therapy: Are PDCs the Next Generation of ADCs?
Baochen Zhang, Mo Wang, Li Sun, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 14, pp. 11469-11487
Closed Access | Times Cited: 5
A novel peptide-drug conjugate for glioma-targeted drug delivery
Jianfen Zhou, Nana Meng, Linwei Lu, et al.
Journal of Controlled Release (2024) Vol. 369, pp. 722-733
Closed Access | Times Cited: 3
Discovery of novel HER2 targeting peptide-camptothecin conjugates with effective suppression for selective cancer treatment
Hanyu Wu, Yunxiao Liu, Jiaqi Zhou, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107371-107371
Closed Access | Times Cited: 3
Novel Drug Delivery Systems: An Important Direction for Drug Innovation Research and Development
Qian Chen, Zhen Yang, Haoyu Liu, et al.
Pharmaceutics (2024) Vol. 16, Iss. 5, pp. 674-674
Open Access | Times Cited: 3
Recent progress of chemical methods for lysine site-selective modification of peptides and proteins
Jian Li, Jinjin Chen, Qi-Long Hu, et al.
Chinese Chemical Letters (2024), pp. 110126-110126
Closed Access | Times Cited: 3
Self-modifying NanoEnhancers facilitating lysosomal escape for cGAS-STING cascading activation in tumor immunotherapy
Yanni Ge, Yuheng Bao, An Shao, et al.
Nano Today (2024) Vol. 57, pp. 102391-102391
Closed Access | Times Cited: 3
Predicting Peptide Permeability Across Diverse Barriers: A Systematic Investigation
Xiaorong Tan, Qianhui Liu, Yanpeng Fang, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 8, pp. 4116-4127
Closed Access | Times Cited: 3
Luminescent iridium(iii)–peptide bioconjugates for bioanalytical and biomedical applications
Shaozhen Jing, Xiaolei Wu, Daniel Shiu‐Hin Chan, et al.
Inorganic Chemistry Frontiers (2024) Vol. 11, Iss. 12, pp. 3400-3417
Closed Access | Times Cited: 2
Drug Delivery Opportunities in Esophageal Cancer: Current Treatments and Future Prospects
Robert C. Sabatelle, Yolonda L. Colson, Uma M. Sachdeva, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 7, pp. 3103-3120
Open Access | Times Cited: 2
Emerging Trends in Dissolving-Microneedle Technology for Antimicrobial Skin-Infection Therapies
Rui Luo, Huihui Xu, Qiaoni Lin, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1188-1188
Open Access | Times Cited: 2
Development of LAG-3/FGL1 blocking peptide and combination with radiotherapy for cancer immunotherapy
Yuzhen Qian, Yixuan Sun, Peishang Shi, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 3, pp. 1150-1165
Open Access | Times Cited: 6
Peptide-ligand conjugate based immunotherapeutic approach for targeted dismissal of non-structural protein 1 of dengue virus: A novel therapeutic solution for mild and severe dengue infections
Varshita Srivastava, Priya Godara, Sudip Prasad Jena, et al.
International Journal of Biological Macromolecules (2024) Vol. 260, pp. 129562-129562
Closed Access | Times Cited: 1
Dual FGFR-targeting and pH-activatable ruthenium–peptide conjugates for targeted therapy of breast cancer
João Franco Machado, Marco de Sá, Inês Pires, et al.
Dalton Transactions (2024) Vol. 53, Iss. 18, pp. 7682-7693
Open Access | Times Cited: 1
Targeted Drug Conjugates in Cancer Therapy: Challenges and Opportunities
Geng Jia, Yuqi Jiang, Xiaoyang Li
Pharmaceutical Science Advances (2024) Vol. 2, pp. 100048-100048
Open Access | Times Cited: 1
Intermolecular Sulfur Atom Transfer Cascade Enabled Late-Stage Introduction of Sulfilimines into Peptides
Zeyuan He, Yuyang Liu, Guangjun Bao, et al.
Chemical Science (2024)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top